Administration of human FSH (hFSH) during the diestrus phase in cyclic rats is followed by a reduction in the preovulatory LH surge. This inhibitory action of FSH involves a decrease in the stimulatory effect of gonadotrope progesterone receptor (PR) activation, in a ligand-dependent (progesterone) and -independent (GNRH) manner. PR activation and action are mandatory for LH surge, and are dependent on the phosphorylation of serine (Ser) residues. Together with this post-translational modification, PR is marked for downregulation by proteasome machinery. These experiments used the western blotting technique to measure pituitary expression of PR-A and PR-B isoforms and phosphorylation levels of Ser294 and Ser400 PR-B in rats bearing i) hFSH treatment or ii) PR downregulation. Treatment with hFSH reduced LH secretion and increased that of estradiol in proestrus afternoon. hFSH injections, without altering PR-A and PR-B content or ratio, caused a reduction in phosphorylation of Ser294 and Ser400 but only when pituitaries were previously challenged with progesterone or GNRH for 2 h. However, while pSer294 levels increased after 2 h of pituitary incubation with progesterone or GNRH, those of pSer400 were not modified by these in vitro treatments. Finally, progesterone had a biphasic effect: in 2-h incubations increased pituitary PR-A and PR-B content, but after 8 h caused downregulation and altered PR-A:PR-B ratio. The results provide a potential mechanism through which LH levels are decreased by hFSH administration and better understanding of the control of PR expression and phosphorylation in rat pituitaries.

Download full-text PDF

Source
http://dx.doi.org/10.1530/REP-14-0592DOI Listing

Publication Analysis

Top Keywords

pr-a pr-b
12
progesterone receptor
8
expression phosphorylation
8
ser294 ser400
8
pr-b content
8
progesterone gnrh
8
progesterone
6
phosphorylation
5
hfsh
5
understanding regulation
4

Similar Publications

Breast cancer is one of the most diagnosed cancers worldwide. The insulin-like growth factor (IGF) system promotes proliferation and survival in breast cancer cells and is regulated by 6 insulin-like growth factor binding proteins (IGFBPs). The IGFBPs sequester IGFs to prolong their half-life and attenuate binding to insulin-like growth factor 1 receptor (IGF1R).

View Article and Find Full Text PDF

The progesterone receptor (PR) is a steroid-responsive nuclear receptor with two isoforms: PR-A and PR-B. Disruption of PR-A:PR-B signaling is associated with breast cancer through interactions with oncogenic co-regulatory proteins (CoRs). However, molecular details of isoform-specific PR-CoR interactions remain poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how specific microRNAs (miRNAs) affect progesterone resistance in endometriosis patients.
  • It analyzed samples from 18 control, eutopic, and ectopic groups using next-generation sequencing and qRT-PCR to assess miRNA and receptor expressions.
  • Key findings showed that certain miRNAs were upregulated in ectopic tissue and that ERα and ERβ expression levels varied, suggesting that miRNAs may contribute to progesterone resistance and could serve as potential biomarkers or therapeutic targets in endometriosis.
View Article and Find Full Text PDF
Article Synopsis
  • The progesterone receptor (PR) has two isoforms, PR-A and PR-B, which play different roles in reproductive tissues, and their imbalance is linked to breast cancer.
  • This study used structural mass spectrometry to explore how PR interacts with co-regulatory proteins SRC3 and p300, revealing new binding details and changes during complex assembly.
  • The findings challenge existing models of how nuclear receptors function, offering insights into the activation mechanisms of PR when bound to various ligands.
View Article and Find Full Text PDF

Ovarian clear cell carcinoma (OCCC) is often considered a relatively platinum-resistant malignancy. The aim of this study was to explore the influence of progesterone receptor (PR) expression levels on platinum sensitivity and survival outcomes in people with OCCC. A retrospective analysis was conducted with 80 people with OCCC who underwent surgery followed by adjuvant chemotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!